GSK

1,620

-1.7%↓

HLN.UK

331.8

+0.58%↑

STJ

1,293

+0.58%↑

HIK

1,841

+0.82%↑

GSK

1,620

-1.7%↓

HLN.UK

331.8

+0.58%↑

STJ

1,293

+0.58%↑

HIK

1,841

+0.82%↑

GSK

1,620

-1.7%↓

HLN.UK

331.8

+0.58%↑

STJ

1,293

+0.58%↑

HIK

1,841

+0.82%↑

GSK

1,620

-1.7%↓

HLN.UK

331.8

+0.58%↑

STJ

1,293

+0.58%↑

HIK

1,841

+0.82%↑

GSK

1,620

-1.7%↓

HLN.UK

331.8

+0.58%↑

STJ

1,293

+0.58%↑

HIK

1,841

+0.82%↑

Search

AstraZeneca PLC

Closed

SectorHealthcare

12,598 1.32

Overview

Share price change

24h

Current

Min

12396

Max

12644

Key metrics

By Trading Economics

Income

211M

3.1B

Sales

1.3B

15B

P/E

Sector Avg

27.859

35.739

Dividend yield

2.85

Profit margin

21.067

Employees

94,300

EBITDA

18M

5.1B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+10.82% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

2.85%

3.08%

Next Earnings

6 Nov 2025

Market Stats

By TradingEconomics

Market Cap

4.6B

172B

Previous open

12596.68

Previous close

12598

News Sentiment

By Acuity

36%

64%

107 / 371 Healthcare

AstraZeneca PLC Chart

Past performance is not a reliable indicator of future results.

Related News

1 Oct 2025, 08:54 UTC

Major Market Movers

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

8 Sept 2025, 16:13 UTC

Major Market Movers

Dianthus Shares Whipsaw on Strong Trial Results, Safety Concerns

29 Jul 2025, 08:08 UTC

Earnings

AstraZeneca Books Record Quarterly Revenue as U.S, Oncology Boosts Growth -- Update

29 Jul 2025, 06:46 UTC

Earnings

AstraZeneca Books Record Quarterly Revenue as Oncology Boosts Growth

1 Oct 2025, 09:05 UTC

Hot Stocks

Stocks to Watch Wednesday: Nike, Lithium Americas, Arm, Occidental -- WSJ

29 Sept 2025, 09:33 UTC

Market Talk

AstraZeneca's Direct NYSE Listing May Hint at Future Intentions -- Market Talk

29 Sept 2025, 09:08 UTC

Earnings
Hot Stocks

Stocks to Watch Monday: Carnival, GSK, Alibaba -- WSJ

8 Aug 2025, 10:51 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Novartis's Midterm Prospects Look Better Than Roche's -- Market Talk

1 Aug 2025, 11:10 UTC

Hot Stocks

Global Stocks to Watch: Novo Nordisk, AXA, Daimler Truck -- WSJ

29 Jul 2025, 11:02 UTC

Earnings

AstraZeneca 2Q Adj EPS $2.17 >AZN.LN

29 Jul 2025, 11:02 UTC

Earnings

AstraZeneca 2Q EPS $1.58 >AZN.LN

29 Jul 2025, 11:01 UTC

Earnings

AstraZeneca 2Q Rev $14.5B >AZN.LN

29 Jul 2025, 11:00 UTC

Earnings

AstraZeneca Results: H1 and Q2 2025

29 Jul 2025, 08:00 UTC

Market Talk
Earnings

AstraZeneca Holding Back on a Guidance Upgrade Disappoints -- Market Talk

29 Jul 2025, 07:53 UTC

Market Talk
Earnings

AstraZeneca Continues to Deliver Under U.S. Tariff Threat -- Market Talk

29 Jul 2025, 07:26 UTC

Market Talk
Earnings

AstraZeneca Shares Look Undervalued -- Market Talk

29 Jul 2025, 06:03 UTC

Earnings

Analysts Saw AstraZeneca 2Q Total Revenue at $14.15B

29 Jul 2025, 06:03 UTC

Earnings

AstraZeneca 2Q Total Revenue $14.46B

29 Jul 2025, 06:03 UTC

Earnings

Analysts Saw AstraZeneca 2Q Core EPS at $2.16

29 Jul 2025, 06:03 UTC

Earnings

AstraZeneca 2Q Core EPS $2.17

29 Jul 2025, 06:02 UTC

Earnings

AstraZeneca Sees Core EPS Increasing by a Low Double-Digit Percentage

29 Jul 2025, 06:02 UTC

Earnings

AstraZeneca Sees Total Revenue Increasing by a High Single-Digit Percentage

29 Jul 2025, 06:02 UTC

Earnings

AstraZeneca Backs 2025 View

29 Jul 2025, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Rev $14.46B

29 Jul 2025, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Adj EPS $2.17

29 Jul 2025, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Pretax Pft $3.13B

29 Jul 2025, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Net Pft $2.45B

29 Jul 2025, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Oper Pft $3.51B

29 Jul 2025, 06:00 UTC

Earnings

AstraZeneca PLC 2Q EPS $1.57

28 Jul 2025, 10:51 UTC

Market Talk

U.S.-EU Tariff Deal, Earnings Could Keep Pharma Rally Going -- Market Talk

Peer Comparison

Price change

AstraZeneca PLC Forecast

Price Target

By TipRanks

10.82% upside

12 Months Forecast

Average 13,801.92 GBX  10.82%

High 18,000 GBX

Low 10,900 GBX

Based on 12 Wall Street analysts offering 12 month price targets forAstraZeneca PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

9

Buy

3

Hold

0

Sell

Sentiment

By Acuity

107 / 371 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
help-icon Live chat